Starling Oncology (STLN) Cash from Operations (QoQ) (2020 - 2026)
Powered by 
Analysis
Starling Oncology (STLN) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 639.05% |
| Mar 31, 2026 | -168.51% |
| Dec 31, 2025 | 125.60% |
| Sep 30, 2025 | -23.80% |
| Jun 30, 2025 | -104.53% |
| Mar 31, 2025 | -224.70% |
| Dec 31, 2024 | 388.40% |
| Sep 30, 2024 | 105.23% |
| Jun 30, 2024 | 1.40% |
| Mar 31, 2024 | -307.99% |
| Dec 31, 2023 | 53.15% |
| Sep 30, 2023 | 4.04% |
| Jun 30, 2023 | 43.96% |
| Mar 31, 2023 | -10.40% |
| Dec 31, 2022 | 31.38% |
| Sep 30, 2022 | -96.54% |
| Jun 30, 2022 | 38.88% |
| Mar 31, 2022 | 27.23% |
| Dec 31, 2021 | -771.03% |
| Sep 30, 2021 | 62.43% |